Biotech Startups

Tasca Therapeutics develops novel cancer therapies using mass spectrometry-based proteomics to identify cancer-causing proteins with auto-palmitoylation modifications, targeting previously unknown binding pockets for difficult-to-treat cancers. The company's lead program, CP-383, is in preclinical development with expected clinical trial entry in 2025.

1 investor

Tasteomics develops Peakaroma, a natural taste receptor and aroma modulator that enhances consumer liking of food products while reducing salt and formulation costs. It serves food manufacturers across categories such as processed dairy, condiments, plant-based products, soups, and fillings.

1 investor

Tata Capital Healthcare Fund is a private equity fund focused on investing in healthcare and life sciences businesses in India. It manages multiple fund vintages (TCHF I, II, and III) that back companies across the healthcare sector.

1 investor

TauC3 Biologics is a biotechnology company developing therapies for neurodegenerative diseases, with a focus on tau-related and Alzheimer's disease drug discovery. It brings together drug development and neuroscience expertise to advance treatments for CNS disorders.

1 investor

Tavira Therapeutics develops an AAV delivery platform for gene therapy that uses modular, post-manufacture enzymatic modification of AAV vectors to target intended tissues more accurately. The technology aims to improve delivery efficiency of AAV vector cargo to the right cells and reduce unintended side effects.

1 investor

Tavo Biotherapeutics develops novel treatments for glaucoma and retinal diseases, focusing on disease-modifying therapies that target the root biological mechanisms of vision loss. The company is advancing TAV-001, a topical therapy that modulates the autonomic nervous system to reduce intraocular pressure, improve blood flow to the optic nerve, and provide neuroprotection.

1 investor

Taxa Biotechnologies operates a platform for metabolic and genetic engineering of plants, offering protein engineering, DNA assembly, transient experiments, and stable transformation as a service without lab access. Its products are designed to avoid regulatory approval so they can be sold to consumers in the United States immediately after development.

1 investor

TAZ develops anti-aging products and drug discovery research focused on cellular senescence removal and longevity science. The company provides biomarker testing services, contract product development, and drug candidates to extend healthspan in an aging society.

1 investor

TBT Pharma is a biotech company developing repurposed generic drugs to replace topical steroids as the standard of care for skin conditions such as psoriasis, chronic wounds, and orphan skin diseases. Its approach relies on clinically validated data and exclusive patent licenses from NYU and Northwestern.

1 investor

A biotech company developing engineered T-cell therapies for cancer, using an AI-based platform to optimize T-cell culture and a novel single-domain TCR structure built on mRNA technology. It operates its own GMP-compatible cleanroom for production.

1 investor

Teal (Tealomics) operates a proteomics and multi-omic analytics platform that maps molecular changes in human biology to support precision medicine research, with a focus on the biology of aging and chronic disease. It partners with life science organizations to accelerate drug discovery.

1 investor

Designs and manufactures medical imaging and particle therapy equipment for cancer treatment and diagnostic visualization. Products include ultrasound systems for brachytherapy procedures, cyclotrons for radiopharmaceutical production, and synchrotrons for particle therapy.

1 investor

Tech4Meat develops cultivated meat using cellular agriculture, creating protein foods without intensive animal farming. The company targets consumers seeking sustainable, ethical meat alternatives with minimal environmental impact.

1 investor

Technical Safety Services provides regulatory compliance, testing, certification, calibration, and maintenance services for laboratory equipment and controlled environments used by life sciences and healthcare organizations. The company offers professional services including commissioning, qualification, validation, and decommissioning across research, manufacturing, and patient care facilities.

1 investor

TECregen develops regenerative biologic therapies aimed at thymus regeneration and restoring immune function, using ligand engineering, targeted delivery, and functional screening. Its therapeutics target immune decline, cancer, and inflammatory disease.

1 investor

TEKMOF develops Metal Organic Frameworks (MOFs) using kinetic-controlled design for molecular trapping, adsorption, and molecular structure determination. It offers porous materials, molecular structure analysis consulting, and analysis equipment and software for the pharmaceutical, food, environmental, and energy sectors.

1 investor

Teknimed engineers and manufactures biomaterials used to restore bones and repair ligaments, including bone cements for surgical applications. It sells to surgeons, healthcare professionals, and distributors internationally.

1 investor

Teknova develops reagents and custom buffer solutions for AAV (adeno-associated virus) downstream processing in gene therapy workflows. The company leverages 30 years of manufacturing expertise to address bottlenecks in AAV production for researchers and biotech organizations.

1 investor

Tekton Research is a multi-specialty clinical research site organization founded in 2006 that conducts Phase 1-4 trials by partnering with pharmaceutical sponsors and contract research organizations. The company operates both embedded physician practices and standalone research centers led by clinical experts in cardiometabolic care, obesity, neurology, and psychiatry.

1 investor

Telepathic (Telepath Technologies) develops non-invasive brain-computer interfaces that read, interpret, and transmit neural signals in real time without surgery or implants. It combines hardware, software, and AI to enable communication and interaction between humans and machines.

1 investor

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices. The page does not describe the company's products or business activities.

1 investor

Telica Microbials develops biological insecticides derived from a bitter natural substance to control thrips and mites at low doses, using a proprietary formulation. Its botanical plant-protection products are aimed at agricultural pest control without harmful effects on bees.

1 investor

Tellgen is a Chinese in vitro diagnostics company that develops, manufactures, and sells diagnostic products and reagents for clinical laboratories. The company specializes in tumor markers, HPV detection, genetic mutation testing, autoimmune disease markers, and biochemical reagents using technologies including flow cytometry, chemiluminescence, and mass spectrometry.

1 investor

Tellus Therapeutics is a biopharmaceutical company developing therapeutics. The about page primarily details the background of its board chairman.

1 investor